GMSRX
Price
$14.72
Change
-$0.08 (-0.54%)
Updated
Jul 31 closing price
Net Assets
273.82M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

GMSRX vs VSCIX

GMSRX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
GMSRX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMSRX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. GMSRX (274M). VSCIX pays higher dividends than GMSRX: VSCIX (1.23) vs GMSRX (0.10). GMSRX was incepted earlier than VSCIX: GMSRX (19 years) vs VSCIX (29 years). GMSRX (1.06) is less costly to investors than VSCIX (0.03). VSCIX is a more actively managed with annual turnover of: 17.00 vs. GMSRX (14.57). GMSRX has a lower initial minimum investment than VSCIX: GMSRX (0) vs VSCIX (5000000). GMSRX annual gain was more profitable for investors over the last year : 30.29 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. GMSRX (18.55).
GMSRXVSCIXGMSRX / VSCIX
Total Expense Ratio1.010.033,367%
Annual Report Gross Expense Ratio1.060.033,533%
Fund Existence19 years29 years-
Gain YTD18.24314.591125%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets274M189B0%
Annual Yield % from dividends0.101.238%
Returns for 1 year30.2922.58134%
Returns for 3 years40.6443.4494%
Returns for 5 years18.5535.1353%
Returns for 10 years16.93156.0711%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C